Table 2 DEGs and the respective biological process in DF-1 cells upon ARV infection. DEGs with fold change > 2 are listed
| Â | Gene-id | Gene-name | Description | Keywords of biological process | Fold change | |
|---|---|---|---|---|---|---|
10 hpi | 18 hpi | |||||
Up | ENSGALG00000016400 | RSAD2 | Radical S-adenosyl methionine domain containing 2 | antiviral defense, innate immunity, et al. | 6.9368 | 3.2553 |
ENSGALG00000006384 | IFIT5 | Interferon induced protein with tetratricopeptide repeats 5 | antiviral defense, innate immunity, et al. | 6.7163 | 3.3529 | |
ENSGALG00000013723 | OASL | 2′-5′-oligoadenylate synthetase-like | antiviral defense, innate immunity, et al. | 6.2188 | 3.2579 | |
ENSGALG00000013575 | ISG12(2) | Interferon-stimulated genes 12 (2) | – | 6.0596 | 2.2561 | |
ENSGALG00000016142 | Mx | Myxovirus resistance | antiviral defense, innate immunity, et al. | 5.5442 | 2.653 | |
ENSGALG00000028982 | CMPK2 | Cytidine monophosphate (UMP-CMP) kinase 2 | Pyrimidine biosynthesis | 4.1368 | 2.3091 | |
ENSGALG00000009479 | SAMD9L | Sterile alpha motif domain containing protein 9-like | endosomal vesicle fusion | 3.5798 | 2.8676 | |
ENSGALG00000006138 | HELZ2 | Helicase with zinc finger domain 2 | Transcription regulation | 2.9797 | 2.4167 | |
ENSGALG00000016964 | EPSTI1 | Epithelial stromal interaction 1 | – | 2.2115 | 1.7528 | |
Novel00328 | predicted: TRIM25-like | Tripartite motif containing 25 | antiviral defense, innate immunity, et al. | 2.1606 | – | |
Novel00773 | predicted: EEA1-like | Early endosome antigen 1-like | endocytosis, vesicle fusion, et al. | 2.1431 | – | |
Down | ENSGALG00000010791 | LEXM | Lymphocyte expansion molecule | positive regulation of cell proliferation, et al. | −5.4359 | – |
ENSGALG00000000607 | GPR37L1 | G protein-coupled receptor 37 like 1 | positive regulation of MAPK cascade, et al. | −5.2343 | – | |
ENSGALG00000002742 | TMEM132B | Transmembrane protein 132B | – | −2.6179 | – | |
Novel01111 | lncRNA | Uncharacterized LOC107053801 | – | −2.4302 | – | |